A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation

BACKGROUND: Bone and mineral disorders commonly affect kidney transplant (KTx) recipients and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat bone loss in such patients, but there is concern that these drugs might induce adynamic bone disease (ABD). METHODS: I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Marques, Igor Denizarde Bacelar, Araújo, Maria Júlia Correia Lima Nepomuceno, Graciolli, Fabiana Giorgetti, dos Reis, Luciene Machado, Pereira, Rosa Maria R., Alvarenga, Jackeline C., Custódio, Melani Ribeiro, Jorgetti, Vanda, Elias, Rosilene Motta, Moysés, Rosa Maria Affonso, David-Neto, Elias
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6362629/
https://ncbi.nlm.nih.gov/pubmed/30606784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018060656
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados